Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In Spain- Projections Based On The Dual VII Trial
Abstract
Authors
FJ Ampudia P Mezquita A Ramirez de Arellano A Basse B Hunt